Cargando…
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT)
The targeted therapy with tyrosine kinase inhibitors (TKIs) against the epidermal growth factor receptor mutation (EGFRm) in advanced non-small cell lung cancer (NSCLC) changed the treatment paradigm. REFLECT study (NCT04031898) explored EGFR/T790M testing and treatment patterns in EGFRm NSCLC patie...
Autores principales: | Janžič, Urška, Turnšek, Nina, Dediu, Mircea, Donev, Ivan Shterev, Lupu, Roxana, Teodorescu, Gabriela, Ciuleanu, Tudor E., Pluzanski, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406426/ https://www.ncbi.nlm.nih.gov/pubmed/36005198 http://dx.doi.org/10.3390/curroncol29080460 |
Ejemplares similares
-
Treatment patterns, testing practices, and outcomes in the pre-FLAURA
era for patients with EGFR mutation-positive advanced NSCLC: a retrospective
chart review (REFLECT)
por: Addeo, Alfredo, et al.
Publicado: (2021) -
Real-world Outcomes, Treatment Patterns and T790M Testing Rates in Non-small Cell Lung Cancer Patients Treated with First-line First- or Second-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors from the Slovenian Cohort of the REFLECT Study
por: Turnsek, Nina, et al.
Publicado: (2022) -
Perspectives for Cancer Care and Research in Central and Eastern Europe
por: Zielinski, Christoph C., et al.
Publicado: (2023) -
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations
por: Janzic, Urska, et al.
Publicado: (2023) -
Treatment Patterns and Real-world Evidence for Stage III Non-small Cell Lung Cancer in Central and Eastern Europe
por: Zemanova, Milada, et al.
Publicado: (2020)